Related Experiment Video
Updated: Nov 29, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Small molecule CDS-3078 induces G2/M phase arrest and mitochondria-mediated apoptosis in HeLa cells
Yuanxin Zhang1, Pengcheng Li1, Jiamin Rong1
1College of Biology and Food Engineering, Jilin Institute of Chemical Technology, Jilin, Jilin 132022, P.R. China.
Abstract:
The tumor suppressor p53 serves important roles in cell cycle arrest and apoptosis, and its activation increases the sensitivity of cancer cells to radiotherapy or chemotherapy. In the present study, the small molecule 2-[1-(4-(benzyloxy)phenyl)-3-oxoisoindolin-2-yl)-2-(4-methoxyphenyl)] acetic acid (CDS-3078) significantly increased p53 mRNA expression levels in a dose-dependent manner. Treatment with CDS-3078 increased p53 expression levels and p53-mediated activation of its downstream target genes in HeLa cells. Additionally, p53+/+ HeLa cells treated with CDS-3078 presented with dysfunctional mitochondria, as indicated by the decrease in Bcl-2 levels, the increase in Bcl-2 homologous antagonist killer and the increase in cytochrome c release from the mitochondria to the cytoplasm. The present results suggested that CDS-3078 treatment significantly induced G2/M phase cell cycle arrest. Therefore, CDS-3078 administration induced apoptosis via p53-mediated cell cycle arrest, causing mitochondrial dysfunction and resulting in apoptotic cell death in cervical cancer cells. Collectively, the present results suggested that CDS-3078 may be a potential anticancer agent.
Insights
The novel compound CDS-3078 activates the tumor suppressor p53, inducing cell cycle arrest and apoptosis in cervical cancer cells. This suggests CDS-3078 is a potential anticancer agent.
Area of Science:
- Molecular Biology
- Cancer Research
- Pharmacology
Background:
- The tumor suppressor p53 is crucial for cell cycle arrest and apoptosis.
- p53 activation enhances cancer cell sensitivity to therapies.
- Cervical cancer remains a significant global health concern.
Purpose of the Study:
- To investigate the effect of the small molecule CDS-3078 on p53 expression and function.
- To determine the mechanism by which CDS-3078 induces cell death in cancer cells.
Main Methods:
- Treatment of HeLa cells (p53+/+) with varying doses of CDS-3078.
- Analysis of p53 mRNA and protein expression levels.
- Assessment of downstream target gene activation.
- Evaluation of mitochondrial function (Bcl-2, BAX, cytochrome c release).
- Cell cycle analysis (G2/M phase arrest).
Main Results:
- CDS-3078 significantly increased p53 mRNA and protein expression in a dose-dependent manner.
- CDS-3078 treatment led to p53-mediated activation of target genes.
- Mitochondrial dysfunction was observed, including decreased Bcl-2 and increased BAX and cytochrome c release.
- CDS-3078 induced G2/M phase cell cycle arrest.
Conclusions:
- CDS-3078 induces apoptosis in cervical cancer cells through p53-mediated cell cycle arrest and mitochondrial dysfunction.
- CDS-3078 demonstrates potential as an anticancer therapeutic agent.
Related Concept Videos
Inhibition of Cdk Activity
Positive Regulator Molecules
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...

